Daniel J. Gerritzen Sells 5,310 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) General Counsel Daniel J. Gerritzen sold 5,310 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $132,006.60. Following the completion of the sale, the general counsel now owns 110,767 shares in the company, valued at $2,753,667.62. The trade was a 4.57 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

OrthoPediatrics Stock Performance

Shares of KIDS opened at $25.15 on Thursday. The business’s fifty day simple moving average is $24.79 and its two-hundred day simple moving average is $25.53. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. OrthoPediatrics Corp. has a 12 month low of $21.02 and a 12 month high of $35.99. The company has a market cap of $610.82 million, a price-to-earnings ratio of -20.45 and a beta of 1.22.

OrthoPediatrics (NASDAQ:KIDS) last issued its earnings results on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. The business had revenue of $52.67 million for the quarter, compared to the consensus estimate of $51.16 million. During the same period last year, the business posted ($0.23) EPS. Research analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Analyst Ratings Changes

KIDS has been the topic of several recent research reports. Needham & Company LLC restated a “buy” rating and issued a $42.00 price target on shares of OrthoPediatrics in a research note on Wednesday, March 5th. Stifel Nicolaus cut their price target on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a research note on Wednesday, March 5th. Finally, Truist Financial cut their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th.

Hedge Funds Weigh In On OrthoPediatrics

Hedge funds and other institutional investors have recently modified their holdings of the company. Wellington Management Group LLP lifted its holdings in shares of OrthoPediatrics by 16.2% during the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock valued at $23,944,000 after buying an additional 122,846 shares during the period. Barclays PLC lifted its holdings in shares of OrthoPediatrics by 319.3% during the 3rd quarter. Barclays PLC now owns 25,298 shares of the company’s stock valued at $686,000 after buying an additional 19,264 shares during the period. Geode Capital Management LLC lifted its holdings in shares of OrthoPediatrics by 2.1% during the 3rd quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock valued at $10,615,000 after buying an additional 7,972 shares during the period. Mutual of America Capital Management LLC lifted its holdings in shares of OrthoPediatrics by 195.1% during the 3rd quarter. Mutual of America Capital Management LLC now owns 107,609 shares of the company’s stock valued at $2,917,000 after buying an additional 71,146 shares during the period. Finally, Centiva Capital LP bought a new position in shares of OrthoPediatrics during the 3rd quarter valued at $319,000. 69.05% of the stock is owned by institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.